Delaney Dennis R Acquires 579 Shares of Danaher Corporation $DHR

Delaney Dennis R increased its position in shares of Danaher Corporation (NYSE:DHRFree Report) by 2.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 25,407 shares of the conglomerate’s stock after acquiring an additional 579 shares during the period. Danaher makes up about 2.6% of Delaney Dennis R’s holdings, making the stock its 19th biggest position. Delaney Dennis R’s holdings in Danaher were worth $5,019,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. MGO One Seven LLC increased its holdings in Danaher by 485.7% during the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after acquiring an additional 20,813 shares during the period. Chicago Capital LLC increased its holdings in Danaher by 11.6% during the 2nd quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock worth $2,634,000 after acquiring an additional 1,391 shares during the period. UniSuper Management Pty Ltd increased its holdings in Danaher by 1.6% during the 1st quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after acquiring an additional 2,667 shares during the period. Asahi Life Asset Management CO. LTD. bought a new stake in Danaher during the 1st quarter worth approximately $539,000. Finally, Horizon Financial Services LLC increased its holdings in Danaher by 20,400.0% during the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate’s stock worth $1,681,000 after acquiring an additional 8,160 shares during the period. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on DHR. Redburn Partners set a $220.00 target price on shares of Danaher in a report on Wednesday. Guggenheim reissued a “buy” rating and issued a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Evercore ISI boosted their price target on shares of Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 7th. Bank of America cut their price target on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research note on Wednesday, October 8th. Seventeen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $244.60.

View Our Latest Stock Report on DHR

Danaher Price Performance

Shares of Danaher stock opened at $202.53 on Monday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.41. The stock has a market capitalization of $145.02 billion, a price-to-earnings ratio of 43.09, a price-to-earnings-growth ratio of 2.88 and a beta of 0.77. The company has a fifty day moving average of $200.66 and a 200-day moving average of $197.07. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion during the quarter, compared to analysts’ expectations of $5.83 billion. During the same quarter in the prior year, the company earned $1.72 EPS. The firm’s revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio is 27.23%.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 11.10% of the company’s stock.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.